DAX24.186 -0,5%Est505.721 -0,6%MSCI World4.343 -0,1%Top 10 Crypto11,86 -3,2%Nas23.195 -1,7%Bitcoin76.985 +0,1%Euro1,1737 ±-0,0%Öl61,12 -0,7%Gold4.302 +0,5%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Rheinmetall 703000 NVIDIA 918422 Lufthansa 823212 Bayer BAY001 Siemens Energy ENER6Y Deutsche Telekom 555750 Volkswagen (VW) vz. 766403 Oracle 871460 Allianz 840400 RENK RENK73 Broadcom A2JG9Z DroneShield A2DMAA Novo Nordisk A3EU6F Mercedes-Benz Group (ex Daimler) 710000 BASF BASF11
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
DAX verabschiedet sich schwächer ins Wochenende -- US-Börsen schließen in Rot -- Broadcom mit starken Zahlen -- lululemon, BioNTech, RENK, Rheinmetall, HENSOLDT, NEL, Canopy & Co. im Fokus
Top News
Berkshire Hathaway oder Broadcom: Welche Aktie bis 2030 mehr Potenzial hat Berkshire Hathaway oder Broadcom: Welche Aktie bis 2030 mehr Potenzial hat
Tesla-Aktie in der Europa-Krise: Warum mehr dahintersteckt als schwache Verkaufszahlen Tesla-Aktie in der Europa-Krise: Warum mehr dahintersteckt als schwache Verkaufszahlen
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

Akero Therapeutics Aktie

Kaufen
Verkaufen
46,89 EUR +0,14 EUR +0,30 %
BMN
54,65 USD +0,10 USD +0,18 %
NAS
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

Marktkap.3,85 Mrd. EUR

Div. Rendite0,00%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKNA2PLNP

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS00973Y1082

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolAKRO

Akero Therapeutics Aktien News

DatumMeistgelesen
PR NewswireBerger Montague PC Investigates Akero Therapeutics, Inc. and Its Board of Directors for Breach of Fiduciary Duties and Violations of Federal Securities Laws (NASDAQ: AKRO)
PR Newswire$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger-CRTAF, AKRO, NIC, and BRNS
PR NewswireBerger Montague PC Investigates Akero Therapeutics, Inc. and Its Board of Directors for Breach of Fiduciary Duties and Violations of Federal Securities Laws (NASDAQ: AKRO)
PR NewswireBerger Montague PC Investigates Akero Therapeutics, Inc. and Its Board of Directors for Breach of Fiduciary Duties and Violations of Federal Securities Laws (NASDAQ: AKRO)
MotleyFoolWhy Akero Therapeutics Stock Trounced the Market on Thursday
PR NewswireShareholder Alert: The Ademi Firm investigates whether Akero Therapeutics Inc. is obtaining a Fair Price for its Public Shareholders
BenzingaNovo Nordisk To Acquire Liver Disease Focused Akero Therapeutics For Around $5 Billion
ZacksIs Akero Therapeutics (AKRO) Stock Outpacing Its Medical Peers This Year?
ZacksZacks Industry Outlook Highlights Halozyme Therapeutics, Akero Therapeutics, Kiniska Pharmaceuticals, ANI Pharmaceuticals and Twist BioScience
ZacksHas Akero Therapeutics (AKRO) Outpaced Other Medical Stocks This Year?
ZacksDoes Akero Therapeutics (AKRO) Have the Potential to Rally 59.14% as Wall Street Analysts Expect?
ZacksAre Medical Stocks Lagging Akero Therapeutics (AKRO) This Year?
GlobeNewswireAkero Therapeutics and HistoIndex Present New Analyses of Phase 2b HARMONY Trial in Oral and Poster Presentations at the EASL Congress 2025
GlobeNewswireAkero Therapeutics Presents Week 96 Results from Phase 2b SYMMETRY Clinical Trial of Efruxifermin in Patients with Compensated Cirrhosis Caused by MASH Showing Fibrosis Improvement without Worsening o
GlobeNewswireAkero Therapeutics Announces Publication of Phase 2b SYMMETRY Trial in the New England Journal of Medicine
BenzingaAkero Therapeutics, Brinker International And Viavi Are Among Top Mid Cap Gainers Last Week (Jan 27-Jan 31): Are The Others In Your Portfolio?
ZacksThe Zacks Analyst Blog Highlights Sage Therapeutics, Biogen, Cytokinetics and Akero Therapeutics
BenzingaLiver Disease-Focused Akero Therapeutics Stock Soars Over 100% On Monday - Here's Why
PR NewswireINVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Akero Therapeutics, Inc. to Contact Law Firm
PR NewswireSHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Akero Therapeutics, Inc. (NASDAQ: AKRO)
PR NewswireSHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Akero Therapeutics, Inc. (NASDAQ: AKRO)
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Akero Therapeutics, Inc. - AKRO
PR NewswireSHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Akero Therapeutics
PR NewswireIMPORTANT JUNE DEADLINE REMINDER: The Schall Law Firm Encourages Investors in Akero Therapeutics, Inc. with Losses to Contact the Firm
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Akero Therapeutics, Inc. - AKRO
PR NewswireAKRO Investors: Reminder - Important Deadline in Securities Fraud Class Action Lawsuit Akero Therapeutics, Inc.
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Akero Therapeutics, Inc. - AKRO
PR NewswireAKRO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Akero Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
PR NewswireAKRO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Akero Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Akero Therapeutics, Inc. - AKRO
PR NewswireAdemi LLP Investigates Claims of Securities Fraud against Akero Therapeutics, Inc.

Akero Therapeutics News

Akero Therapeutics News: auf dieser Seite finden Sie alle Akero Therapeutics News und Nachrichten zur Akero Therapeutics Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Akero Therapeutics News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Akero Therapeutics News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.